CN205434001U - D shape intervention formula artificial heart valve - Google Patents
D shape intervention formula artificial heart valve Download PDFInfo
- Publication number
- CN205434001U CN205434001U CN201620107104.7U CN201620107104U CN205434001U CN 205434001 U CN205434001 U CN 205434001U CN 201620107104 U CN201620107104 U CN 201620107104U CN 205434001 U CN205434001 U CN 205434001U
- Authority
- CN
- China
- Prior art keywords
- sub
- support
- stent
- shaped
- heart valve
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000003709 heart valve Anatomy 0.000 title claims abstract description 74
- 238000012800 visualization Methods 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 4
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 3
- 210000002216 heart Anatomy 0.000 abstract description 20
- 206010040007 Sense of oppression Diseases 0.000 abstract description 4
- 238000013461 design Methods 0.000 abstract description 4
- 210000002489 tectorial membrane Anatomy 0.000 abstract description 3
- 241000446313 Lamella Species 0.000 abstract 1
- 210000004115 mitral valve Anatomy 0.000 description 13
- 210000001519 tissue Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 239000010408 film Substances 0.000 description 5
- 238000011065 in-situ storage Methods 0.000 description 5
- 230000006378 damage Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 210000002837 heart atrium Anatomy 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000003516 pericardium Anatomy 0.000 description 4
- 206010027727 Mitral valve incompetence Diseases 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 239000013039 cover film Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 210000003540 papillary muscle Anatomy 0.000 description 3
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000005003 heart tissue Anatomy 0.000 description 2
- 208000018578 heart valve disease Diseases 0.000 description 2
- 238000010030 laminating Methods 0.000 description 2
- 210000005246 left atrium Anatomy 0.000 description 2
- 210000005240 left ventricle Anatomy 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 230000002861 ventricular Effects 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010013012 Dilatation ventricular Diseases 0.000 description 1
- 206010061996 Heart valve stenosis Diseases 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 208000003430 Mitral Valve Prolapse Diseases 0.000 description 1
- 229910000566 Platinum-iridium alloy Inorganic materials 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000003157 atrial septum Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 210000003698 chordae tendineae Anatomy 0.000 description 1
- 208000016569 congenital mitral valve insufficiency Diseases 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 201000007119 infective endocarditis Diseases 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000013152 interventional procedure Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000005907 mitral valve insufficiency Diseases 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical class [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000596 ventricular septum Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Prostheses (AREA)
Abstract
The utility model provides a D shape intervention formula artificial heart valve, including the support, set up in the inboard lamella leaf of support and set up the tectorial membrane on the support body wall, the support is including the sub - support of first sub - support, second and the sub - support of third that connect gradually, first sub - support be the network management, network management that the sub - support of second appeared for D for the cross section, the sub - support of third is loudspeaker and describes the network management, the biggest pipe diameter of first sub - support is the same with the pipe diameter of the sub - support of second, and the minimum pipe diameter of the sub - support of third is the same with the pipe diameter of the sub - support of second. Through the network management that appears for the cross section the support of second design for D, erect with the D shape intervention formula artificial heart valve medium counts that has now and count the cross -section and compare for the circular shape tubulose, the shape of the sub - support of second is identical with the holding space shape that the mitral primary body wall of normal position encloses to the problem of avoiding its oppression to the heart efferent tract to cause the patient other complication to appear when using has improved the success rate of operation.
Description
Technical Field
The utility model relates to the technical field of medical equipment, in particular to D-shaped intervention type artificial heart valve.
Background
The heart is a very important organ of a human body and provides power for blood circulation of the human body, the heart is divided into a left part and a right part, each part comprises a ventricle and an atrium, the ventricle and the atrium are separated by a ventricular septum and an atrial septum, and valves for preventing blood backflow are arranged among the atrium, the ventricle and the artery.
The mitral valve is located between the left atrium and the left ventricle, and acts as a one-way valve to ensure that blood flows from the left atrium to the left ventricle and through a certain flow. The mitral valve complex is a complex set of devices that function and dissect structures, commonly thought of as including the annulus, leaflets, chordae tendinae, and papillary muscles. The function of the mitral valve depends on the integrity of its physiological structure. When the normal mitral valve is closed, the two valve leaflets are in the same plane and closely coapt, so that the backflow of the ventricular blood flow can be completely blocked. To achieve this result, the mitral annulus is required to be of a proper size, the leaflets have a complete structure, the papillary muscle contracts and pulls the chordae tendineae to support the leaflets, the left ventricular muscle contracts and generates a proper closing force, and the ventricles are required to have normal shapes and functions. Abnormalities in any of these factors can lead to Mitral Regurgitation (MR).
The most common cause is rheumatic valvular heart disease, and the most common cause is rheumatic valvular heart disease. Other common causes include mitral valve prolapse, mitral valve degeneration, mitral annulus calcification, papillary muscle failure due to myocardial ischemia, functional mitral insufficiency due to left ventricular enlargement, infectious endocarditis, congenital malformations, and the like. Surgical valve replacement surgery has large trauma and long recovery time of patients, so that the old patients are often contraindicated to surgery due to the old, weak constitution, serious disease or combination of other diseases.
In recent years, with the progress of interventional therapy technology, transcatheter heart valve replacement or repair is rapidly developed and applied clinically, and a satisfactory effect is achieved. Interventional prosthetic heart valves are implanted into the heart's native mitral valve by minimally invasive interventional procedures to replace or repair the damaged native valve for relevant work. The interventional artificial heart valve mainly comprises a support and valve blades arranged in the support, and does not need to open a chest in the operation process, so that the trauma is small, the postoperative recovery is quick, and a new solution is provided for heart valve stenosis patients who cannot prolong the life or relieve the pain of the patients by the conventional treatment means at present.
But because the intervention treatment technology has short time, the application of the intervention treatment technology also faces more problems. For example, some interventional prosthetic heart valves are prone to breakage during use due to insufficient support; the degree of coincidence between the stent and the physiological structure of the natural valve is not enough, and perivalvular leakage is easy to occur; the stent structure easily compresses the cardiac outflow tract; too long and large a stent structure hurts the heart; the unreasonable design of the developing points influences the operation. In response to the problems with existing interventional prosthetic heart valves, those skilled in the art are constantly searching for solutions.
Disclosure of Invention
An object of the utility model is to provide a D shape intervention formula artificial heart valve to there is the problem of oppression heart outflow tract when solving current intervention formula artificial heart valve and using.
In order to solve the technical problem, the utility model provides a D shape intervenes formula artificial heart valve, intervene formula artificial heart valve includes: the support comprises a support, valve leaflets arranged on the inner side of the support and a covering film arranged on the wall of the support; wherein,
the support comprises a first sub-support, a second sub-support and a third sub-support which are sequentially connected, wherein the first sub-support is a net pipe, the second sub-support is a net pipe with a D-shaped cross section, and the third sub-support is a trumpet-shaped net pipe; the maximum pipe diameter of the first sub-support is the same as that of the second sub-support, and the minimum pipe diameter of the third sub-support is the same as that of the second sub-support.
Optionally, in the D-shaped interventional prosthetic heart valve, the second sub-stent includes a straight body wall and an arc body wall, the straight body wall and the arc body wall are mutually connected to form a mesh tube with a D-shaped cross section, and an inclination angle of the body wall of the third sub-stent relative to the straight body wall of the second sub-stent is greater than an inclination angle of the body wall of the third sub-stent relative to the arc body wall of the second sub-stent.
Optionally, in the D-shaped interventional prosthetic heart valve, the first sub-stent is a truncated cone-shaped mesh tube, and a body wall of the first sub-stent is inclined by 10 to 60 degrees with respect to a body wall of the second sub-stent.
Optionally, in the D-shaped interventional prosthetic heart valve, a barb is disposed on a body wall of the first or second sub-stent, and a free end of the barb is inclined in a direction away from the free end of the first sub-stent.
Optionally, in the D-shaped interventional prosthetic heart valve, a visualization point is further included, and the visualization point is disposed on the third sub-stent and/or on a cover film on the third sub-stent.
Optionally, in the D-shaped interventional prosthetic heart valve, the number of the visualization points is 3, wherein 2 visualization points are disposed on the third sub-stent connected to the straight body wall of the second sub-stent, and the other 1 visualization point is disposed on the cover membrane of the third sub-stent connected to the curved body wall of the second sub-stent.
Optionally, in the D-shaped interventional prosthetic heart valve, the number of the leaflets is at least two.
Optionally, in the D-shaped intervention type artificial heart valve, the leaflet is a valve or a tissue engineering valve made of biological tissue or high polymer material.
Optionally, in the D-shaped interventional artificial heart valve, the first sub-stent or the second sub-stent is provided with a leaflet suture hole, and the leaflet is sutured on the stent through the leaflet suture hole.
Optionally, in the D-shaped interventional prosthetic heart valve, the stent is made of nickel-titanium alloy, and the covering film is made of one or more of PET, e-PTFE and pericardium.
The utility model provides a D shape intervention formula artificial heart valve, D shape intervention formula artificial heart valve includes the support, sets up the valve leaf in the support inboard and sets up the tectorial membrane on the support body wall, and the support includes first sub-support, second sub-support and the third sub-support that connects gradually, and first sub-support is the network management, and the second sub-support is the network management that the cross section is the D shape, and the third sub-support is tubaeform network management; the maximum pipe diameter of the first sub-support is the same as that of the second sub-support, and the minimum pipe diameter of the third sub-support is the same as that of the second sub-support. Compared with the prior D-shaped interventional artificial heart valve in which the stent is designed into a tubular shape with a circular section, the shape of the second sub-stent is matched with the shape of the accommodating space enclosed by the wall of the original body of the in-situ mitral valve, so that the problem that other complications of a patient occur due to the compression of the second sub-stent on the outflow tract of the heart is avoided when the stent is used, and the success rate of the operation is improved.
Drawings
Fig. 1 is a schematic structural view of a D-shaped interventional prosthetic heart valve according to an embodiment of the present invention after being implanted into an in situ mitral valve of a heart;
fig. 2 is a front view of a stent for a D-shaped interventional prosthetic heart valve in an embodiment of the present invention;
fig. 3 is a front view of a D-shaped interventional prosthetic heart valve after stent coating according to an embodiment of the present invention;
fig. 3a is a top view of the stent of fig. 3 after leaflets have been sutured inside.
In the figure: a bracket 1; a leaflet 2; coating a film 3; a first sub-mount 10; a second sub-mount 11; leaflet suture holes 110; a flat body wall 111; an arcuate body wall 112; a third sub-mount 12; a barb 4; a conveying connecting part 5; and a development point 6.
Detailed Description
The D-shaped interventional prosthetic heart valve according to the present invention will be described in further detail with reference to the accompanying drawings and specific embodiments. The advantages and features of the present invention will become more fully apparent from the following description and appended claims. It should be noted that the drawings are in simplified form and are not to precise scale, and are provided for convenience and clarity in order to facilitate the description of the embodiments of the present invention.
Before explaining the present invention in detail, the principle and idea of the present invention will be explained first. There is the problem of oppression heart outflow tract when applying to current intervention formula artificial heart valve, the utility model discloses an inventor is through long-term experimental verification discovery, the reason that leads to above-mentioned phenomenon lies in, because current intervention formula artificial heart valve's supporting structure is the tubulose, because the cross sectional shape in holding intervention formula artificial heart valve's space is not circular, but D shape, consequently in the support is back in the normal position mitral valve of tubulose intervention formula artificial heart valve imbeds the heart, can cause the oppression to the straight lateral wall of accommodation space, cause the outflow tract of heart to become narrow. Based on the discovery of this problem, provided the technical scheme of the utility model, the technical scheme of the utility model mainly follow the shape design of support and go on.
Fig. 1 is a schematic structural diagram of the D-shaped interventional artificial heart valve according to the present invention after being implanted into an in-situ mitral valve of a heart. Fig. 2 is a front view of the stent of the D-shaped interventional prosthetic heart valve of the present invention. Fig. 3 is a front view of a D-shaped interventional prosthetic heart valve after stent coating according to an embodiment of the present invention. Fig. 3a is a top view of the stent of fig. 3 after leaflets have been sutured inside the stent. As shown in fig. 2, 3-3 a, the D-shaped interventional prosthetic heart valve of the present invention comprises: the support comprises a support 1, valve leaflets 2 arranged on the inner side of the support 1 and a covering film 3 arranged on the body wall of the support 1; the stent 1 comprises a first sub-stent 10, a second sub-stent 11 and a third sub-stent 12 which are sequentially connected, wherein the first sub-stent 10 is a mesh tube, the second sub-stent 11 is a mesh tube with a D-shaped cross section, and the third sub-stent 12 is a trumpet-shaped mesh tube; the maximum pipe diameter of the first sub-support 10 is the same as that of the second sub-support 11, and the minimum pipe diameter of the third sub-support 12 is the same as that of the second sub-support 11.
Referring to fig. 3, the second sub-stent includes a straight body wall 111 and an arc body wall 112, and the straight body wall 111 and the arc body wall 112 are connected to each other to form a mesh tube with a D-shaped cross section, so that the structural shape of the prepared D-shaped interventional artificial heart valve conforms to the cross-sectional shape of the space for accommodating the D-shaped interventional artificial heart valve, and the compression on the cardiac outflow tract due to unreasonable stent structure is avoided; the inclination angle of the body wall of the third sub-stent relative to the straight body wall 111 of the second sub-stent is larger than the inclination angle of the body wall of the third sub-stent relative to the arc body wall 112 of the second sub-stent, so that the morphological distribution of native tissues is further conformed, and the damage of the third sub-stent structure to heart tissues is avoided. In practical application, after the D-shaped interventional artificial heart valve is placed in an in-situ mitral valve of a heart, the straight body wall of the second sub-stent is close to one side of a cardiac outflow tract.
Furthermore, the first sub-stent is a cone frustum-shaped net tube, so that the length of the whole stent is reduced, and the injury of the stent to tissues around the heart due to overlong length after the stent is implanted into the heart is avoided.
Referring to fig. 2, the first sub-mount 10, the second sub-mount 11 and the third sub-mount 12 are coaxial, and the three are different in shape. When the stent is actually prepared, the same original mesh tube is adopted, the original mesh tube is divided into three sections for a shaping process, when the second sub-stent 11 is prepared, the section of original mesh tube is shaped into a mesh tube with a D-shaped cross section, the edge of one end of the original mesh tube is contracted along the radial direction of the original mesh tube to present the shape of a part marked with 10 in figure 2, wherein the inclined angle theta of the body wall of the first sub-stent 10 relative to the body wall of the second sub-stent 11 is 10-60 degrees, and preferably 30 degrees.
Referring to fig. 2 and 3, a barb 4 is disposed on the body wall of the first sub-bracket 10 or the second sub-bracket 11, the free end of the barb 4 is inclined in a direction away from the free end of the first sub-bracket 10, and an angle between the barb 4 and the body wall of the first sub-bracket 10 or the second sub-bracket 11 is 10 degrees to 80 degrees, preferably 60 degrees. The length of the barb is 3 mm-10 mm. When the positioning device is applied, the barbs 4 penetrate into tissues around the valve to play a role in positioning the D-shaped interventional artificial heart valve. Here, the number of the barbs 4 is plural, and a plurality of the barbs 4 are uniformly distributed on the outer circumference of the first sub-stent 10 or the second sub-stent 11.
Specifically, D shape intervention formula artificial heart valve in this embodiment can follow it radially to stretch out and draw back, when D shape intervention formula artificial heart valve is carried in the installation, in order to facilitate closely laminating with the target tissue to form sufficient blood flow passageway, the utility model discloses with above-mentioned second sub-bracket with the structure matched with structure design of third sub-bracket is identical for the physiological structure with natural valve (especially identical with the natural physiological structure of the surrounding tissue of mitral valve), thereby makes it have certain self-align function, is convenient for fix a position the release fast accurately, and the release after closely laminating blood flow passageway, difficult emergence is shifted, this structure is convenient for the tectorial membrane with surrounding tissue cooperation to form block structure simultaneously, is favorable to avoiding the valve to leak all around.
In practical application, the D-shaped interventional artificial heart valve is accommodated in a conveying device and implanted in a patient, when the D-shaped interventional artificial heart valve reaches a target position, the D-shaped interventional artificial heart valve is released, at the moment, a support of the D-shaped interventional artificial heart valve is rapidly expanded from a compressed state, as shown in fig. 1, after the D-shaped interventional artificial heart valve is released, the first sub-support is positioned in a ventricle, the third sub-support is positioned in an atrium, the third sub-support serves as a blood inlet of blood, the first sub-support serves as a blood outlet of blood, since the pipe diameter of the third sub-support is larger than that of the second sub-support, when the heart is in diastole, the natural plate ring tissue can block the third sub-support to prevent the D-shaped interventional artificial heart valve from sliding into the ventricle, and when the heart is in systole, due to the effect of the barb, the D-shaped interventional artificial heart valve can be prevented from moving into the ventricle, consequently based on the utility model discloses a supporting structure can prevent more effectively that D shape from taking place to shift under blood pressure and the washing out after the release of intervention formula artificial heart valve, has prolonged the life after D shape intervention formula artificial heart valve releases, has reduced its injury to surrounding tissue.
As shown in fig. 3a, the distribution position and the shape of the valve leaflets 2 can be known, in this embodiment, the number of the valve leaflets 2 is at least two, and the valve leaflets are biological tissues (such as porcine pericardium, bovine pericardium, porcine heart valve, bovine heart valve, etc.), valves made of polymer materials, or tissue engineering valves. Wherein, the valve leaflet includes the rectangle portion and with the arc portion that the rectangle portion is connected, the valve leaflet of adopting this shape is convenient for cooperate the suture, and the hemodynamics of gained valve is effectual. As shown in fig. 2, in order to install the leaflet in the stent, the first sub-stent or the second sub-stent of the present invention is provided with a leaflet suture hole 110, and the leaflet is sutured to the stent through the leaflet suture hole 110.
Further, referring to fig. 2 and 3, in order to facilitate the combination of the D-shaped interventional prosthetic heart valve with the delivery device in the delivery stage, a delivery connection part 5 is provided at the free end of the first sub-stent, and the number of the delivery connection parts 5 is at least 2.
Referring to fig. 2 and 3a, in order to position and observe the position of the D-shaped interventional artificial heart valve, there are 3 visualization points 6 disposed on the third sub-stent and/or on the cover film on the third sub-stent, wherein 2 visualization points are disposed on the third sub-stent connected to the straight body wall of the second sub-stent, and the other 1 visualization point is disposed on the cover film of the third sub-stent connected to the arc body wall of the second sub-stent, and 3 visualization points form a plane, and when the D-shaped interventional artificial heart valve reaches the target position when being placed in the heart, two visualization points disposed on the third sub-stent connected to the straight body wall are on the same straight line, and are observed and displayed as the same point. Specifically, if the developing points 6 are arranged on the third sub-bracket, developing holes need to be arranged on the outer wall of the third sub-bracket, and developing media are filled in the developing holes; if the development sites 6 are provided in the coating, a developing medium is added to the coating material at the positions where the development sites 6 need to be provided. The developing medium is one or more of platinum-iridium alloy (Pt/Ir), platinum metal (Pt) and tantalum metal (Ta).
Preferably, the stent is made of nickel-titanium alloy, and the covering membrane is made of one or more of PET, e-PTFE and pericardium materials.
Preferably, the grid shape of the cylindrical net tube of the second sub-stent is designed into a diamond shape, so that the supporting force of the D-shaped interventional artificial heart valve in use is improved, and the problem of breakage of the stent caused by insufficient supporting force is avoided.
In summary, in the D-shaped interventional artificial heart valve provided by the present invention, the D-shaped interventional artificial heart valve includes a stent, valve leaflets disposed inside the stent, and a covering film disposed on the wall of the stent, the stent includes a first sub-stent, a second sub-stent, and a third sub-stent connected in sequence, the first sub-stent is a mesh tube, the second sub-stent is a mesh tube with a D-shaped cross section, and the third sub-stent is a trumpet-shaped mesh tube; the maximum pipe diameter of the first sub-support is the same as that of the second sub-support, and the minimum pipe diameter of the third sub-support is the same as that of the second sub-support. Compared with the prior D-shaped interventional artificial heart valve in which the stent is designed into a tubular shape with a circular section, the shape of the second sub-stent is matched with the shape of the accommodating space enclosed by the wall of the original body of the in-situ mitral valve, so that the problem that other complications occur to a patient due to the compression of the second sub-stent on the outflow tract of the heart is avoided when the stent is used; on the other hand, the first sub-stent in the utility model is designed into a truncated cone-shaped mesh tube, thereby shortening the overall length of the stent, avoiding the damage to the heart caused by the long-length penetration of the stent into the surrounding heart tissues and improving the success rate of the operation; on the other hand, as the body wall of the first sub-stent or the second sub-stent is provided with the barbs, the barbs can penetrate into tissues around the valve after the heart valve is implanted to a specific position to play a positioning role, so that the D-shaped intervention type artificial heart valve is not easy to displace and leak around the valve after being released; on the other hand, based on the utility model discloses the position that the development point set up is comparatively reasonable, accords with the demand of operation.
The above description is only for the preferred embodiment of the present invention and is not intended to limit the scope of the present invention, and any modification and modification made by those skilled in the art according to the above disclosure are all within the scope of the claims.
Claims (10)
1. A D-shaped interventional prosthetic heart valve, comprising: the support comprises a support, valve leaflets arranged on the inner side of the support and a covering film arranged on the wall of the support; wherein,
the support comprises a first sub-support, a second sub-support and a third sub-support which are sequentially connected, wherein the first sub-support is a net pipe, the second sub-support is a net pipe with a D-shaped cross section, and the third sub-support is a trumpet-shaped net pipe; the maximum pipe diameter of the first sub-support is the same as that of the second sub-support, and the minimum pipe diameter of the third sub-support is the same as that of the second sub-support.
2. The D-shaped interventional prosthetic heart valve of claim 1, wherein the second sub-stent comprises a straight wall and an arcuate wall interconnected to form a mesh tube having a D-shaped cross-section, and wherein the angle of inclination of the body wall of the third sub-stent relative to the straight wall of the second sub-stent is greater than the angle of inclination of the body wall of the third sub-stent relative to the arcuate wall of the second sub-stent.
3. The D-shaped interventional prosthetic heart valve of claim 1, wherein the first sub-stent is a frustoconically shaped mesh tube, and a body wall of the first sub-stent is inclined from 10 degrees to 60 degrees with respect to a body wall of the second sub-stent.
4. The D-shaped interventional prosthetic heart valve of claim 1, wherein a body wall of the first or second sub-stent is provided with barbs, free ends of the barbs being inclined in a direction away from the free ends of the first sub-stent.
5. The D-shaped interventional prosthetic heart valve of claim 2, further comprising visualization points disposed on the third sub-stent and/or on a cover on the third sub-stent.
6. The D-shaped interventional prosthetic heart valve of claim 5, wherein the number of visualization points is 3, with 2 visualization points disposed on the third sub-stent connected with the straight body wall of the second sub-stent and 1 other visualization point disposed on the cover of the third sub-stent connected with the curved body wall of the second sub-stent.
7. The D-shaped interventional prosthetic heart valve of claim 1, wherein the number of leaflets is at least two.
8. The D-shaped interventional prosthetic heart valve of claim 7, wherein the leaflet is a biological tissue, a valve made of a polymeric material, or a tissue engineered valve.
9. The D-shaped interventional prosthetic heart valve of any one of claims 1-8, wherein the first or second sub-stent has leaflet suture holes disposed thereon through which the leaflets are sutured to the stent.
10. The D-shaped interventional prosthetic heart valve of any one of claims 1-8, wherein the stent is a nickel titanium alloy and the cover is one of PET, e-PTFE, and pericardial material.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201620107104.7U CN205434001U (en) | 2016-02-02 | 2016-02-02 | D shape intervention formula artificial heart valve |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201620107104.7U CN205434001U (en) | 2016-02-02 | 2016-02-02 | D shape intervention formula artificial heart valve |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN205434001U true CN205434001U (en) | 2016-08-10 |
Family
ID=56581312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201620107104.7U Active CN205434001U (en) | 2016-02-02 | 2016-02-02 | D shape intervention formula artificial heart valve |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN205434001U (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105520792A (en) * | 2016-02-02 | 2016-04-27 | 上海纽脉医疗科技有限公司 | D-shaped invasive prosthetic heart valve |
| CN106175987A (en) * | 2016-08-31 | 2016-12-07 | 上海纽脉医疗科技有限公司 | Cardiac valve prosthesis |
| CN107890382A (en) * | 2017-12-20 | 2018-04-10 | 乐普（北京）医疗器械股份有限公司 | Positionable and retrievable transcatheter implantable aortic valve device |
| WO2019062366A1 (en) * | 2017-09-29 | 2019-04-04 | 上海微创心通医疗科技有限公司 | Heart valve prosthesis |
| CN110621260A (en) * | 2017-01-23 | 2019-12-27 | 科菲瓣膜技术有限公司 | Replacement mitral valve |
| CN112716658A (en) * | 2021-01-20 | 2021-04-30 | 上海捍宇医疗科技股份有限公司 | Transcatheter atrioventricular valve replacement system |
| US11058535B2 (en) | 2017-01-23 | 2021-07-13 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
| US11617646B2 (en) | 2015-05-14 | 2023-04-04 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
-
2016
- 2016-02-02 CN CN201620107104.7U patent/CN205434001U/en active Active
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11617646B2 (en) | 2015-05-14 | 2023-04-04 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
| CN105520792A (en) * | 2016-02-02 | 2016-04-27 | 上海纽脉医疗科技有限公司 | D-shaped invasive prosthetic heart valve |
| US10842621B2 (en) | 2016-08-31 | 2020-11-24 | Shanghai Newmed Medical Co., Ltd. | Artificial cardiac valve |
| CN106175987A (en) * | 2016-08-31 | 2016-12-07 | 上海纽脉医疗科技有限公司 | Cardiac valve prosthesis |
| WO2018040244A1 (en) * | 2016-08-31 | 2018-03-08 | 上海纽脉医疗科技有限公司 | Artificial cardiac valve |
| US11090158B2 (en) | 2017-01-23 | 2021-08-17 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
| CN110621260A (en) * | 2017-01-23 | 2019-12-27 | 科菲瓣膜技术有限公司 | Replacement mitral valve |
| JP2020505980A (en) * | 2017-01-23 | 2020-02-27 | セフィア・バルブ・テクノロジーズ, インコーポレイテッドCephea Valve Technologies, Inc. | Replacement mitral valve |
| CN112566590A (en) * | 2017-01-23 | 2021-03-26 | 科菲瓣膜技术有限公司 | Replacement mitral valve |
| US11058535B2 (en) | 2017-01-23 | 2021-07-13 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
| JP7046078B2 (en) | 2017-01-23 | 2022-04-01 | セフィア・バルブ・テクノロジーズ，インコーポレイテッド | Replacement mitral valve |
| US11633278B2 (en) | 2017-01-23 | 2023-04-25 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
| US12290437B2 (en) | 2017-01-23 | 2025-05-06 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
| WO2019062366A1 (en) * | 2017-09-29 | 2019-04-04 | 上海微创心通医疗科技有限公司 | Heart valve prosthesis |
| WO2019119674A1 (en) * | 2017-12-20 | 2019-06-27 | 乐普（北京）医疗器械股份有限公司 | Aortic valve device and delivery device |
| CN107890382A (en) * | 2017-12-20 | 2018-04-10 | 乐普（北京）医疗器械股份有限公司 | Positionable and retrievable transcatheter implantable aortic valve device |
| CN112716658A (en) * | 2021-01-20 | 2021-04-30 | 上海捍宇医疗科技股份有限公司 | Transcatheter atrioventricular valve replacement system |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105520792B (en) | A kind of D-shaped insertion type artificial cardiac valve | |
| CN205434001U (en) | D shape intervention formula artificial heart valve | |
| CN105726167A (en) | Involved artificial heart valve prosthesis | |
| US10842621B2 (en) | Artificial cardiac valve | |
| CN109414321B (en) | Device for treating valve regurgitation | |
| CN104274259B (en) | The artificial valve prosthese of a kind of band lobe leaf clamping device | |
| JP7036556B2 (en) | Stent with valve for replacement of heart mitral and tricuspid valves | |
| CN104055604B (en) | The heart valve implantation instrument of a kind of band anchoring device | |
| CN103338726B (en) | Coaptation-enhancing implants, systems and methods | |
| US9510948B2 (en) | Systems, devices and methods for repair of heart valve lesions | |
| DK2549953T3 (en) | STENTS FOR THE HEART VALVE PROTECTION | |
| US9662208B2 (en) | Devices and methods for surgical and percutaneous repair of heart valve lesions | |
| US20140025163A1 (en) | Systems, devices and methods for surgical and precutaneous replacement of a valve | |
| EP2959866A1 (en) | Heart valve prosthesis | |
| CN209377809U (en) | A kind of heart valve prosthesis prosthese and its bracket | |
| CN111110403A (en) | Heart valve device with anchoring ring and using method thereof | |
| CN212382790U (en) | A heart valve device with an anchoring ring | |
| JP2017531547A (en) | System and method for heart valve therapy | |
| CN104799974A (en) | Involvement type prosthetic heart valve stent with barbs and preparation method thereof | |
| CN204709077U (en) | A kind of insertion type artificial cardiac valve | |
| US10918479B2 (en) | Heart valve prosthesis | |
| CN205434002U (en) | Intervention formula artificial heart valve | |
| CN204709078U (en) | A kind of insertion type artificial cardiac valve induction system | |
| CN113558822B (en) | An interventional mitral valve replacement system | |
| CN204600797U (en) | A kind of supporting structure of the insertion type artificial cardiac valve with agnail |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |